CIN
MCID: CRV045
MIFTS: 38

Cervical Intraepithelial Neoplasia (CIN) malady

Categories: Rare diseases

Aliases & Classifications for Cervical Intraepithelial Neoplasia

Aliases & Descriptions for Cervical Intraepithelial Neoplasia:

Name: Cervical Intraepithelial Neoplasia 50 52 69
Cin 45

Classifications:



Summaries for Cervical Intraepithelial Neoplasia

MalaCards based summary : Cervical Intraepithelial Neoplasia, also known as cin, is related to cervix uteri carcinoma in situ and cervicitis. An important gene associated with Cervical Intraepithelial Neoplasia is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways is Validated targets of C-MYC transcriptional activation. The drugs Epinephrine and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include cervix, testes and t cells, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and growth/size/body region

Wikipedia : 71 Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the potentially... more...

Related Diseases for Cervical Intraepithelial Neoplasia

Diseases related to Cervical Intraepithelial Neoplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 66)
id Related Disease Score Top Affiliating Genes
1 cervix uteri carcinoma in situ 11.4
2 cervicitis 11.2
3 squamous cell carcinoma 10.5
4 spondylarthropathy 10.3 CDKN2A MKI67
5 hypocalciuric hypercalcemia, type i 10.3 TERC TERT
6 intellectual disability - hypoplastic corpus callosum - preauricular tag 10.3 TERC TERT
7 papilloma 10.3
8 vaginitis 10.3
9 immunodeficiency due to a classical component pathway complement deficiency 10.3 BIRC5 CDKN2A
10 brachydactyly tibial hypoplasia 10.3 CDKN2A TERT
11 aml with myelodysplasia-related features 10.3 CDKN2A MKI67
12 scn9a-related inherited erythromelalgia 10.3 TERC TERT
13 bladder adenocarcinoma 10.2 CDKN2A MKI67
14 lacrimal gland squamous cell carcinoma 10.2 CDKN2A KRT8
15 early-onset anterior polar cataract 10.2 TERC TERT
16 childhood testicular mixed germ cell tumor 10.2 CDKN2A NME1
17 aortic aneurysm 10.2 CDKN2A VEGFC
18 adenocarcinoma 10.2
19 brachydactyly small stature face anomalies 10.2 KRT17 MKI67
20 endocervicitis 10.2
21 oro-mandibular-limb hypogenesis syndrome 10.2 CDKN2A MKI67
22 acute disseminated encephalomyelitis 10.2 CDKN2A TERT
23 porphyria 10.2 MTHFR ODC1
24 childhood-onset cerebral x-linked adrenoleukodystrophy 10.2 CDKN2A KRT8 MKI67
25 nodular cutaneous amyloidosis 10.2 BIRC5 CDKN2A TERT
26 common bile duct neoplasm 10.2 BIRC5 MKI67 TERT
27 hiv-1 10.2
28 adenocarcinoma in situ 10.2
29 cervical squamous cell carcinoma 10.2
30 thymus squamous cell carcinoma 10.2 CDKN2A KRT17 KRT8
31 uterine cervix leukoplakia 10.1 CDKN2A KRT17
32 maxillary sinus cholesteatoma 10.1 CDKN2A TERT VEGFC
33 nevoid hypermelanosis, linear and whorled 10.1 BIRC5 CDKN2A TERT
34 gastrointestinal stromal tumor 10.1 CDKN2A MKI67 MTHFR
35 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3 10.1 CDKN2A NME1 TERT
36 mediastinum liposarcoma 10.1 CDKN2A KRT8
37 chlamydia 10.1
38 adrenal cortical carcinoma 10.1 CDKN2A NME1 TERT
39 mitochondrial encephalomyopathy 10.0 CDKN2A CFLAR KRT17
40 hepatic flexure cancer 10.0 CDKN2A MKI67 NME1 TERT
41 autonomic nervous system neoplasm 10.0 CDKN2A KRT8 ODC1
42 bacterial vaginosis 10.0
43 retinoblastoma 10.0
44 mucositis 10.0
45 breast malignant phyllodes tumor 9.9 KRT8 MKI67 NME1 VEGFC
46 pediatric germ cell cancer 9.9 CDKN2A KRT8 NME1 VEGFC
47 obesity 9.9
48 conjunctivitis 9.9
49 vaginal cancer 9.9
50 vulvar intraepithelial neoplasia 9.9

Graphical network of the top 20 diseases related to Cervical Intraepithelial Neoplasia:



Diseases related to Cervical Intraepithelial Neoplasia

Symptoms & Phenotypes for Cervical Intraepithelial Neoplasia

GenomeRNAi Phenotypes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 CDC6 MKI67 RBL1

MGI Mouse Phenotypes related to Cervical Intraepithelial Neoplasia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.61 CDKN2A CFLAR KRT17 KRT8 MTHFR NME1
2 mortality/aging MP:0010768 9.36 NME1 ODC1 RBL1 TERT VEGFC BIRC5

Drugs & Therapeutics for Cervical Intraepithelial Neoplasia

Drugs for Cervical Intraepithelial Neoplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 195)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
2
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
3
Aluminum hydroxide Approved Phase 4,Phase 3 21645-51-2
4 Anesthetics Phase 4,Phase 3,Phase 2
5 Vaccines Phase 4,Phase 3,Phase 1,Phase 2
6 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
7 Mydriatics Phase 4,Phase 2
8 Adrenergic Agents Phase 4,Phase 2
9 Adrenergic Agonists Phase 4,Phase 2
10 Adrenergic alpha-Agonists Phase 4,Phase 2
11 Adrenergic beta-Agonists Phase 4,Phase 2
12 Neurotransmitter Agents Phase 4,Phase 2
13 Hormone Antagonists Phase 4,Phase 2
14 Hormones Phase 4,Phase 2
15 Disinfectants Phase 4
16 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
17 Anesthetics, Local Phase 4,Phase 3,Phase 2
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
19 Vasoconstrictor Agents Phase 4,Phase 2
20 Epinephryl borate Phase 4,Phase 3,Phase 2
21 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2
22 Anti-Asthmatic Agents Phase 4,Phase 2
23 Estrogens Phase 4
24 Estrogens, Conjugated (USP) Phase 4
25 Polyhexamethylene biguanide Phase 4
26 Racepinephrine Phase 4,Phase 3,Phase 2
27 Respiratory System Agents Phase 4,Phase 2
28 Autonomic Agents Phase 4,Phase 2
29 Bronchodilator Agents Phase 4,Phase 2
30 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
31 Monophosphoryl lipid A Phase 4
32
Menthol Approved Phase 2, Phase 3 2216-51-5 16666
33
Lidocaine Approved, Vet_approved Phase 3,Phase 2 137-58-6 3676
34
Imiquimod Approved, Investigational Phase 2, Phase 3, Phase 1 99011-02-6 57469
35
Isotretinoin Approved Phase 3 4759-48-2 5538 5282379
36
Fluorouracil Approved Phase 3 51-21-8 3385
37
acetic acid Approved, Nutraceutical Phase 3,Phase 1 64-19-7 176
38
Fenretinide Investigational Phase 3,Phase 2 65646-68-6
39 interferons Phase 2, Phase 3, Phase 1
40 Gastrointestinal Agents Phase 3,Phase 1
41 Immunoglobulins Phase 3
42 Interferon Inducers Phase 2, Phase 3, Phase 1
43 Antibodies Phase 3
44 Antiviral Agents Phase 3,Phase 2,Phase 1
45 Retinamide Phase 3,Phase 2
46
Retinol acetate Phase 3,Phase 1 127-47-9 10245972
47 Adjuvants, Immunologic Phase 2, Phase 3, Phase 1
48 Sodium Channel Blockers Phase 3,Phase 2
49 Hemostatics Phase 3,Phase 2
50 Dermatologic Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 320)
id Name Status NCT ID Phase
1 Can Alternative Treatment Have an Impact on Cervical Dysplasia? Unknown status NCT00842738 Phase 4
2 The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling Unknown status NCT01843478 Phase 4
3 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
4 Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Completed NCT02368054 Phase 4
5 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Completed NCT01544478 Phase 4
6 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
7 Effect of Hormone Replacement Therapy on Lupus Activity Completed NCT00392093 Phase 4
8 Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection Completed NCT01571141 Phase 4
9 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4
10 FASTER-Tlalpan Study Active, not recruiting NCT03105856 Phase 4
11 CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study) Active, not recruiting NCT01895517 Phase 4
12 Effectiveness of Cervical Screening in HPV Vaccinated Women Enrolling by invitation NCT02149030 Phase 4
13 Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines Not yet recruiting NCT03180034 Phase 4
14 HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Not yet recruiting NCT03051516 Phase 4
15 Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) Unknown status NCT01095198 Phase 2, Phase 3
16 Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants Completed NCT00128661 Phase 3
17 ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Completed NCT00941252 Phase 2, Phase 3
18 Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Completed NCT00212381 Phase 3
19 Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Completed NCT02330471 Phase 3
20 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
21 Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) Completed NCT00092521 Phase 3
22 Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit Completed NCT00237562 Phase 3
23 A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women Completed NCT00000758 Phase 3
24 A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3
25 Fenretinide in Treating Patients With Cervical Neoplasia Completed NCT00003075 Phase 3
26 Diindolylmethane in Treating Patients With Abnormal Cervical Cells Completed NCT00462813 Phase 3
27 A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins Completed NCT01929993 Phase 3
28 Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Completed NCT01505920 Phase 3
29 Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion Completed NCT00995020 Phase 3
30 Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 Completed NCT00156026 Phase 3
31 Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women Completed NCT00337818 Phase 3
32 Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015) Completed NCT00092534 Phase 3
33 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine Completed NCT00316706 Phase 3
34 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
35 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Completed NCT01014026 Phase 3
36 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
37 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
38 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed NCT00090220 Phase 3
39 Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors Completed NCT00001073 Phase 3
40 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System Completed NCT00973362 Phase 3
41 Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Recruiting NCT02346227 Phase 3
42 Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions Recruiting NCT02059499 Phase 3
43 Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Recruiting NCT02135419 Phase 3
44 Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix Active, not recruiting NCT02130323 Phase 2, Phase 3
45 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. Active, not recruiting NCT02733068 Phase 3
46 Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine Active, not recruiting NCT01735006 Phase 3
47 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Active, not recruiting NCT02562508 Phase 3
48 Erlotinib Prevention of Oral Cancer (EPOC) Active, not recruiting NCT00402779 Phase 3
49 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Not yet recruiting NCT02669459 Phase 3
50 Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia Terminated NCT01283763 Phase 3

Search NIH Clinical Center for Cervical Intraepithelial Neoplasia

Genetic Tests for Cervical Intraepithelial Neoplasia

Anatomical Context for Cervical Intraepithelial Neoplasia

MalaCards organs/tissues related to Cervical Intraepithelial Neoplasia:

39
Cervix, Testes, T Cells, Endothelial, Monocytes, Skin

Publications for Cervical Intraepithelial Neoplasia

Articles related to Cervical Intraepithelial Neoplasia:

(show top 50) (show all 763)
id Title Authors Year
1
Type-Dependent Association between Risk of Cervical Intraepithelial Neoplasia and Viral Load of Oncogenic Human Papillomavirus Types Other than Types 16 and 18. ( 28052328 )
2017
2
Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. ( 28050798 )
2017
3
Cervical intraepithelial neoplasia (CIN) 3-like squamous cell carcinoma of the cervix: a review of 14 cases with comparison of E-cadherin and cyclin D1 expression in the CIN 3-like and infiltrative tumour elements. ( 27681166 )
2017
4
Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia. ( 28044307 )
2017
5
A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias. ( 27998803 )
2017
6
A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. ( 27697590 )
2017
7
Loop Electrosurgical Excision Procedure Instead of Cold-Knife Conization for Cervical Intraepithelial Neoplasia in Women With Unsatisfactory Colposcopic Examinations: A Systematic Review and Meta-analysis. ( 27977541 )
2016
8
Accuracy of Colposcopically Guided Diagnostic Methods for the Detection of Cervical Intraepithelial Neoplasia. ( 26941452 )
2016
9
Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. ( 26935422 )
2016
10
Clinical investigation of the safety and efficacy of a cervical intraepithelial neoplasia treatment using a hyperthermia device that uses heat induced by alternating magnetic fields. ( 27446569 )
2016
11
Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. ( 27434037 )
2016
12
Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment. ( 27428114 )
2016
13
Risk of head-and-neck cancer following a diagnosis of severe cervical intraepithelial neoplasia: a nationwide population-based cohort study in Denmark. ( 27106016 )
2016
14
Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. ( 26890987 )
2016
15
Glycodelin expression in pregnant patients with cervical intraepithelial neoplasia: a case-control study. ( 26631447 )
2016
16
Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus. ( 27285765 )
2016
17
Incisal margin condition after LEEP for cervical intraepithelial neoplasia patients and prognosis. ( 27446314 )
2016
18
Differential detection of Human Papillomavirus genotypes and cervical intraepithelial neoplasia by four commercial assays. ( 27535689 )
2016
19
Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results. ( 27363060 )
2016
20
Obstetric complications after treatment of cervical intraepithelial neoplasia. ( 27487072 )
2016
21
Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature. ( 27055819 )
2016
22
Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil. ( 27005927 )
2016
23
Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. ( 26962367 )
2016
24
A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia. ( 27764154 )
2016
25
Association between folate status and cervical intraepithelial neoplasia. ( 27026426 )
2016
26
A modified method for the culture of naturally HPV-infected high-grade cervical intraepithelial neoplasia keratinocytes from human neoplastic cervical biopsies. ( 26893760 )
2016
27
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial. ( 26897518 )
2016
28
A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. ( 27981553 )
2016
29
Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia. ( 27418835 )
2016
30
E-cadherin-160 C/A genotypes and cervical intraepithelial neoplasia. ( 27837621 )
2016
31
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. ( 27685805 )
2016
32
Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia. ( 27401842 )
2016
33
Increase in the cervical length after the loop electrosurgical excision procedure for grade III cervical intraepithelial neoplasia. ( 27924675 )
2016
34
Regeneration Process After Cervical Conization for Cervical Intraepithelial Neoplasia. ( 27824745 )
2016
35
Fertility and Early Pregnancy Outcomes Following Conservative Treatment for Cervical Intraepithelial Neoplasia and Early Cervical Cancer. ( 27356074 )
2016
36
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma. ( 27601381 )
2016
37
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial. ( 27541373 )
2016
38
Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital. ( 27797243 )
2016
39
Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia. ( 27824756 )
2016
40
Outcome of Persistent Low-Grade Cervical Intraepithelial Neoplasia Treated With Loop Electrosurgical Excision Procedure. ( 27467826 )
2016
41
Variant-Specific Persistence of Infections with Human Papillomavirus Types 31, 33, 45, 56 and 58 and Risk of Cervical Intraepithelial Neoplasia. ( 27121353 )
2016
42
Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia. ( 27888161 )
2016
43
Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia. ( 27401478 )
2016
44
Cervical intraepithelial neoplasia: screening and management. ( 27487071 )
2016
45
Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. ( 27816370 )
2016
46
Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study. ( 27358257 )
2016
47
Association of -463G/A MPO gene polymorphism and risk of cervical intraepithelial neoplasia. ( 26319155 )
2016
48
The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? ( 27802830 )
2016
49
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women. ( 27317575 )
2016
50
Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden. ( 27177207 )
2016

Variations for Cervical Intraepithelial Neoplasia

Expression for Cervical Intraepithelial Neoplasia

Search GEO for disease gene expression data for Cervical Intraepithelial Neoplasia.

Pathways for Cervical Intraepithelial Neoplasia

Pathways related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.83 BIRC5 NME1 ODC1 TERT

GO Terms for Cervical Intraepithelial Neoplasia

Cellular components related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 intermediate filament GO:0005882 8.8 KRT17 KRT8 NME1

Biological processes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.46 CDC6 CDKN2A NME1 VEGFC
2 negative regulation of gene expression GO:0010629 9.43 NME1 RBL1 TERT
3 cell cycle GO:0007049 9.35 BIRC5 CDC6 CDKN2A MKI67 RBL1
4 replicative senescence GO:0090399 8.62 CDKN2A TERT

Sources for Cervical Intraepithelial Neoplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....